BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
— Blinded data from the ongoing Phase 2 clinical trial of BRTX-100 to be described in poster presentation —
— Company to host webcasted conference call to review data on February 5, 2024 at 8:30am EST —
Related news for (BRTX)
- BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
- BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update
- Today’s Top Performers: MoBot’s Market Review 02/25/25 07:00 PM
- MoBot’s Stock Market Highlights – 02/25/25 06:00 PM
- MoBot’s Stock Market Highlights – 02/20/25 08:00 AM